Simultaneous determination of antiarrhythmia drugs by high-performance thin-layer chromatography.
A method is described for the determination of antiarrhythmia drugs in serum by high-performance thin-layer chromatography. Baseline separations are achieved for all the drugs and clozapine, an internal standard, in two developments with solvents of different polarity. Lidocaine and diphenylhydantoin are scanned at 220 nm after the first development. Procainamide, propranolol and quinidine are scanned at 290 nm after the second development. The relative standard deviation of the determination varies between 3 and 14% depending on the nature of the drug and its concentration.
D000889:Anti-Arrhythmia Agents / Q000097:blood*; D002851:Chromatography, High Pressure Liquid; D002855:Chromatography, Thin Layer; D003024:Clozapine / Q000097:blood; D006801:Humans; D008012:Lidocaine / Q000097:blood; D010672:Phenytoin / Q000097:blood; D011342:Procainamide / Q000097:blood; D011433:Propranolol / Q000097:blood; D011802:Quinidine / Q000097:blood
D000889:Anti-Arrhythmia Agents; D010672:Phenytoin; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine; D003024:Clozapine; D011342:Procainamide